A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

NCT04527107 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Diabetic Retinopathy
Diabetic Macular Edema

Interventions

DRUG: THR-149 dose level 1
DRUG: THR-149 dose level 2
DRUG: THR-149 dose level 3
DRUG: THR-149 0.13mg
DRUG: THR-149 0.13mg + aflibercept 2mg
DRUG: aflibercept 2mg + THR-149 0.13mg
DRUG: Aflibercept 2mg

Sponsor

Oxurion